Gordana Vlahovic Selected Research

Proteins (Proteins, Gene)

10/2014

A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gordana Vlahovic Research Topics

Disease

19	Neoplasms (Cancer) 05/2019 - 01/2003
5	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2014
4	Glioma (Gliomas) 12/2018 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2003
3	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2017
3	Hypoxia (Hypoxemia) 11/2013 - 02/2008
2	Adenocarcinoma 10/2019 - 12/2009
2	Fatigue 09/2017 - 06/2015
2	Thrombocytopenia (Thrombopenia) 06/2015 - 07/2012
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018
1	Inflammation (Inflammations) 12/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Chronic Disease (Chronic Diseases) 09/2017
1	Neoplasm Metastasis (Metastasis) 07/2016
1	Lymphoma (Lymphomas) 06/2015
1	Multiple Myeloma 06/2015
1	Hematologic Neoplasms (Hematological Malignancy) 06/2015
1	Exanthema (Rash) 07/2012
1	Mucositis 07/2012
1	Anemia 05/2012
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 11/2011
1	Adenocarcinoma of Lung 12/2009
1	Carcinoma (Carcinomatosis) 05/2007
1	Rectal Neoplasms (Rectal Cancer) 05/2007
1	Philadelphia Chromosome 01/2003
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2003
1	Leukemia 01/2003

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 01/2018 - 05/2007
4	VaccinesIBA 01/2018 - 03/2016
4	Pharmaceutical PreparationsIBA 01/2018 - 01/2003
2	durvalumabIBA 10/2019 - 05/2019
2	Everolimus FDA Link 01/2018 - 07/2012
2	Panitumumab (Vectibix)FDA Link 01/2018 - 07/2012
1	tremelimumabIBA 10/2019
1	GlucocorticoidsIBA 12/2018
1	poliovirus receptorIBA 12/2018
1	IpilimumabIBA 01/2018
1	AntigensIBA 01/2018
1	ganitumabIBA 01/2018
1	rilotumumabIBA 01/2018
1	NivolumabIBA 01/2018
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 09/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Lysosomal Membrane ProteinsIBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	Protein Subunit VaccinesIBA 01/2017
1	Angiopoietin-1IBA 09/2016
1	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2016
1	B7-H1 AntigenIBA 08/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2015
1	Proteasome InhibitorsIBA 06/2015
1	ixazomibIBA 06/2015
1	Carboplatin (JM8)FDA LinkGeneric 10/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2014
1	navitoclaxIBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	IsotopesIBA 11/2013
1	Epidermal Growth Factor (EGF)IBA 11/2013
1	Dihydrotachysterol (AT 10)IBA 07/2012
1	IronIBA 05/2012
1	HematinicsIBA 05/2012
1	Neuronal Apoptosis-Inhibitory ProteinIBA 11/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2011
1	Biological ProductsIBA 12/2009
1	Cisplatin (Platino)FDA LinkGeneric 12/2009
1	Monoclonal AntibodiesIBA 07/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2008
1	Biomarkers (Surrogate Marker)IBA 07/2008
1	copper pyruvaldehyde bis(N(4)-methylthiosemicarbazone) complexIBA 02/2008
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 02/2008
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2008
1	SurvivinIBA 05/2007
1	Fluorouracil (Carac)FDA LinkGeneric 05/2007
1	EnzymesIBA 01/2003
1	Docetaxel (Taxotere)FDA Link 01/2003
1	Tyrosine (L-Tyrosine)FDA Link 01/2003
1	Imatinib Mesylate (Gleevec)FDA Link 01/2003
1	PlatinumIBA 01/2003
1	Phosphotransferases (Kinase)IBA 01/2003
1	ErbB Receptors (EGF Receptor)IBA 01/2003
1	Gefitinib (Iressa)FDA Link 01/2003

Therapy/Procedure

5	Immunotherapy 01/2018 - 08/2015
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2003
3	Therapeutics 12/2018 - 02/2008
1	Catheters 12/2018
1	Oncolytic Virotherapy 03/2016
1	Radiotherapy 03/2016